Important Safety Information
Emotional Support
All of the emotions and symptoms your loved one experiences may affect the way he or she acts. While some people may not outwardly express their frustrations and anger, others will. This anger may be unintentionally directed toward family members, friends, healthcare professionals, or you. It is important to remember the reasons for the anger and to show understanding.
Giving emotional support is a natural way to help your loved one. But at times, it may also be quite challenging. The following tips may help:
- Talk with your loved one and let them know you are there to help
- Listen to and help your loved one work through many feelings he or she may be having. It is important to consistently provide hope, comfort, and encouragement
- Meet other patients or caregivers who are dealing with NHL. Local advocacy groups can help you with this. These new relationships can help provide information, comfort, and hope. Click here to see a list of cancer organizations. Some of them can connect you with another person who is living with your type of cancer
- Take care of yourself. The better you care for yourself, the better you will be able to care for your loved one
This information does not take the place of talking with your doctor. Discuss with your doctor any questions you have about your medical condition or your treatment.
Indications and Important Safety Information
RITUXAN® (Rituximab) is indicated for the treatment of patients with:
- Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent
- Previously untreated follicular, CD20-positive, B-cell NHL in combination with CVP chemotherapy
- Non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL, as a single agent, after first-line CVP chemotherapy
- Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens
People with serious infections should not receive RITUXAN.
Important Safety Information:
- RITUXAN can cause serious side effects that can lead to death, including: infusion reactions, tumor lysis syndrome (TLS; kidney failure due to fast breakdown of cancer cells), severe skin and mouth reactions, and progressive multifocal leukoencephalopathy (PML; a rare, serious brain infection).
- RITUXAN has also been associated with serious and life-threatening side effects, including: the return of active hepatitis B virus infection with sudden and serious liver problems including liver failure, and death, other serious infections that can lead to death, heart problems, kidney problems, and stomach and serious bowel problems including blockage and tears in the bowel that can sometimes lead to death.
- The most common side effects of RITUXAN seen in patients with non-Hodgkin’s lymphoma were infusion reactions, fever, chills, low white blood cells, infections, body aches, and tiredness. Before starting treatment with RITUXAN it is important to talk to your doctor about your medical history.
- Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects with RITUXAN. For more information, ask your doctor
Please see full Prescribing Information, including Medication Guide.
